Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $171,780 - $780,246
-90,411 Reduced 42.68%
121,438 $299,000
Q2 2022

Aug 12, 2022

BUY
$2.13 - $9.01 $252,720 - $1.07 Million
118,648 Added 127.3%
211,849 $517,000
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $98,897 - $245,511
-15,748 Reduced 14.45%
93,201 $743,000
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $1.6 Million - $3.12 Million
108,949 New
108,949 $1.66 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $426,640 - $589,680
-17,550 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$26.09 - $40.4 $457,879 - $709,020
17,550 New
17,550 $592,000
Q1 2021

May 14, 2021

SELL
$33.06 - $56.93 $1.96 Million - $3.38 Million
-59,300 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$39.09 - $57.4 $1.95 Million - $2.87 Million
49,995 Added 537.29%
59,300 $2.48 Million
Q3 2020

Nov 13, 2020

BUY
$28.43 - $44.67 $264,541 - $415,654
9,305 New
9,305 $403,000
Q1 2020

May 13, 2020

SELL
$7.64 - $27.5 $142,959 - $514,580
-18,712 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$15.02 - $20.57 $281,054 - $384,905
18,712 New
18,712 $302,000
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $444,011 - $647,762
-23,555 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $147,662 - $223,321
8,501 Added 56.47%
23,555 $554,000
Q1 2019

May 13, 2019

SELL
$10.65 - $25.75 $24,186 - $58,478
-2,271 Reduced 13.11%
15,054 $353,000
Q4 2018

Feb 13, 2019

BUY
$9.26 - $16.38 $160,429 - $283,783
17,325 New
17,325 $192,000
Q3 2017

Nov 08, 2017

SELL
$8.89 - $10.4 $90,704 - $106,111
-10,203 Closed
0 $0
Q2 2017

Aug 17, 2017

BUY
N/A
10,203
10,203 $98,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.